Insider Trading activities of Entellus Medical Inc insiders.

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Entellus Medical Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Entellus Medical Inc since year 2005. Table 2 shows the detailed insider transactions of Entellus Medical Inc since 2005. The reporting company's ticker symbol is ENTL. The reporting company's CIK number is 1374128.
The total value of stock buying since 2005 is $18,021,602.
The total value of stock sales since 2005 is $25,912,516.
The total value of stock option exercises since 2005 is $81,564.


Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for Entellus Medical Inc (ENTL).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2017-10 0 $0 52,650 $1,024,666 10,000 $12,400
2017-09 0 $0 27,000 $474,500 25,000 $35,000
2017-05 17,700 $216,618 0 $0 0 $0
2017-01 0 $0 1,188,637 $20,376,428 0 $0
2016-12 0 $0 20,000 $374,934 0 $0
2016-11 0 $0 20,000 $371,500 0 $0
2016-10 0 $0 41,103 $889,985 0 $0
2016-09 0 $0 29,328 $545,294 0 $0
2016-08 0 $0 24,856 $466,850 0 $0
2016-07 0 $0 3,000 $54,447 0 $0
2016-02 0 $0 10,000 $170,000 0 $0
2015-10 0 $0 0 $0 16,100 $19,964
2015-09 0 $0 48,103 $1,052,281 0 $0
2015-08 0 $0 5,000 $111,631 0 $0
2015-04 0 $0 0 $0 1,250 $14,200
2015-02 1,047,352 $17,804,984 0 $0 0 $0

Table 2. Detailed insider stock purchases, sales, and option exercises of Entellus Medical Inc insiders (ENTL)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-10-16 Mensink Kevin L (VP Marketing) Sale 10,000 18.29 182,900
2017-10-16 Mensink Kevin L (VP Marketing) Option Ex 10,000 1.24 12,400
2017-10-09 Peterson Karen E (VP, Regulatory and Quality) Sale 650 20.17 13,109
2017-10-04 Petrick Timothy B (VP, Research & Development) Sale 2,000 20.01 40,026
2017-10-04 Farley Brian E (Director) Sale 30,000 19.91 597,240
2017-10-03 Farley Brian E (Director) Sale 6,028 19.16 115,526
2017-10-02 Farley Brian E (Director) Sale 3,972 19.10 75,865
2017-09-22 Petrick Timothy B (VP, Research & Development) Sale 2,000 18.00 36,000
2017-09-13 Paidosh Stephen R (Vice President, Operations) Sale 25,000 17.54 438,500
2017-09-13 Paidosh Stephen R (Vice President, Operations) Option Ex 25,000 1.40 35,000
2017-05-08 White Robert S. (President and CEO) Buy 10,000 12.24 122,400
2017-05-08 Moen Brent (CFO and Secretary) Buy 6,100 12.21 74,474
2017-05-08 Baltzell Joshua J (Director) Buy 1,600 12.34 19,744
2017-01-31 Essex Woodlands Health Ventures Fund Viii-b Lp (10% Owner) Sale 581,541 17.00 9,886,197
2017-01-31 International Life Sciences Fund Iii (lp1), L.p. (10% Owner) Sale 533,077 17.00 9,062,309
2017-01-13 Peterson Karen E (VP, Regulatory & Quality) Sale 10,000 20.13 201,330
2017-01-13 Farley Brian E (Director) Sale 14,019 20.14 282,314
2017-01-10 Peterson Karen E (VP, Regulatory and Quality) Sale 4,840 19.10 92,444
2017-01-10 Farley Brian E (Director) Sale 4,842 19.10 92,482
2017-01-09 Peterson Karen E (VP, Regulatory and Quality) Sale 5,000 19.12 95,595
2017-01-09 Farley Brian E (Director) Sale 5,000 19.12 95,595
2017-01-04 Peterson Karen E (VP, Regulatory and Quality) Sale 160 19.10 3,056
2017-01-04 Farley Brian E (Director) Sale 158 19.10 3,017
2017-01-03 Peterson Karen E (VP, Regulatory and Quality) Sale 10,000 18.74 187,369
2017-01-03 Farley Brian E (Director) Sale 20,000 18.74 374,720
2016-12-07 Farley Brian E (Director) Sale 5,000 19.10 95,500
2016-12-06 Farley Brian E (Director) Sale 4,348 18.70 81,307
2016-12-05 Farley Brian E (Director) Sale 10,652 18.60 198,127
2016-11-23 Farley Brian E (Director) Sale 5,000 19.00 95,000
2016-11-22 Farley Brian E (Director) Sale 5,000 18.70 93,500
2016-11-18 Farley Brian E (Director) Sale 5,000 18.30 91,500
2016-11-17 Farley Brian E (Director) Sale 5,000 18.30 91,500
2016-10-13 Boiano Margaret A (VP Healthcare Policy&Reimburse) Sale 11,103 20.01 222,215
2016-10-05 Farley Brian E (Director) Sale 30,000 22.26 667,770
2016-09-08 Surek James D (Vice President, Sales) Sale 10,000 18.71 187,150
2016-09-02 Farley Brian E (Director) Sale 11,078 18.62 206,305
2016-09-01 Mensink Kevin L (Vice President, Marketing) Sale 8,000 18.39 147,152
2016-09-01 Farley Brian E (Director) Sale 250 18.75 4,687
2016-08-31 Farley Brian E (Director) Sale 4,356 19.00 82,785
2016-08-30 Farley Brian E (Director) Sale 12,400 19.46 241,254
2016-08-01 Mensink Kevin L (Vice President, Marketing) Sale 8,100 17.63 142,811
2016-07-18 Petrick Timothy B (VP, Research and Development) Sale 3,000 18.15 54,447
2016-02-04 Peterson Karen E (SEE REMARKS) Sale 10,000 17.00 170,000
2015-10-29 Mensink Kevin L (VICE PRESIDENT, MARKETING) Option Ex 16,100 1.24 19,964
2015-09-17 Farley Brian E (EXECUTIVE CHAIRMAN) Sale 4,566 22.00 100,452
2015-09-16 Farley Brian E (EXECUTIVE CHAIRMAN) Sale 918 22.01 20,207
2015-09-15 Farley Brian E (EXECUTIVE CHAIRMAN) Sale 6,432 22.26 143,157
2015-09-14 Farley Brian E (EXECUTIVE CHAIRMAN) Sale 21,187 22.15 469,355
2015-09-02 Surek James D (VICE PRESIDENT, SALES) Sale 15,000 21.27 319,110
2015-08-31 Surek James D (VICE PRESIDENT, SALES) Sale 791 22.20 17,560
2015-08-28 Surek James D (VICE PRESIDENT, SALES) Sale 4,209 22.35 94,071
2015-04-21 Baltzell Joshua J (Director) Option Ex 1,250 11.36 14,200
2015-02-03 White Robert S. (PRESIDENT & COO) Buy 5,882 17.00 99,994
2015-02-03 Mccormick Shawn (Director) Buy 2,941 17.00 49,997
2015-02-03 Essex Woodlands Health Ventures Fund Viii-b Lp (10% Owner) Buy 352,941 17.00 5,999,997
2015-02-03 Sv Life Sciences Fund Iv, L.p. (10% Owner) Buy 317,647 17.00 5,399,999
2015-02-03 Split Rock Partners Management Llc (10% Owner) Buy 352,941 17.00 5,999,997
2015-02-03 Neels Guido J (Director) Buy 15,000 17.00 255,000

Insider trading activities including stock purchases, stock sales, and option exercises of ENTL listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Entellus Medical Inc (symbol ENTL, CIK number 1374128) see the Securities and Exchange Commission (SEC) website.